Validation d'une nouvelle méthode de dosage du tacrolimus en vue de son adaptation posologique: comparaison des résultats sur automate RXL Dimension avec ceux obtenus sur Cobas-Mira
暂无分享，去创建一个
[1] L. Yucetin,et al. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods. , 2005, Clinical biochemistry.
[2] Tatsuro Endo,et al. On-chip micro-flow polystyrene bead-based immunoassay for quantitative detection of tacrolimus (FK506). , 2004, Analytical biochemistry.
[3] Thomas Layloff,et al. Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies , 1992, Pharmaceutical Research.
[4] M. Tuncer,et al. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients. , 2004, Transplantation proceedings.
[5] G. Lensmeyer,et al. Therapeutic Monitoring of Tacrolimus Concentrations in Blood: Semi-Automated Extraction and Liquid Chromatography-Electrospray Ionization Mass Spectrometry , 2001, Therapeutic drug monitoring.
[6] L. Shaw,et al. Analytical validation of the PRO-Trac II ELISA for the determination of tacrolimus (FK506) in whole blood. , 1999, Clinical chemistry.
[7] R. Kershner,et al. Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. , 1996, Transplantation.
[8] U. Christians,et al. Consensus Document: Therapeutic Monitoring of Tacrolimus (FK‐506) , 1995 .